Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis-Reference-Cited by-同舟云学术

Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis

Published:2021-06-08 Issue:12 Volume:236 Page:7938-7965
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Thakur Krishan K.¹,Kumar Aviral¹^ORCID,Banik Kishore¹,Verma Elika¹,Khatoon Elina¹,Harsha Choudhary¹,Sethi Gautam²^ORCID,Gupta Subash C.³,Kunnumakkara Ajaikumar B.¹

Affiliation:

1. Department of Biosciences and Bioengineering, Cancer Biology Laboratory Indian Institute of Technology (IIT) Guwahati Guwahati Assam India

2. Department of Pharmacology, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

3. Department of Biochemistry, Laboratory for Translational Cancer Research Banaras Hindu University (BHU) Varanasi Uttar Pradesh India

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.30463

Reference233 articles.

1. linc00673 (ERRLR01) is a prognostic indicator of overall survival in breast cancer

2. Basal-Like and Triple-Negative Breast Cancers

3. Breast Cancer Before Age 40 Years

4. Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF

5. Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myricetin inhibits 4 T1 breast tumor growth in mice via induction of Nrf-2/GPX4 pathway-mediated Ferroptosis;Toxicology and Applied Pharmacology;2024-07

2. LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p/RBM39 axis;Molecular and Cellular Biochemistry;2024-03-12

3. Ellagic Acid-Gold Nanoparticle Complex as Anticancer Agent in Triple-Negative Breast Cancer Cells;Nano LIFE;2024-03-06

4. Therapeutic potential of tocotrienols as chemosensitizers in cancer therapy;Phytotherapy Research;2024-02-14

5. MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways;Cell Communication and Signaling;2024-02-07